alendronate has been researched along with Injuries, Multiple in 2 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "While alendronate therapy has been shown to decrease the risk of vertebral and femoral neck fractures in postmenopausal osteoporotic patients, recent reports have associated long-term alendronate therapy with unilateral low-energy subtrochanteric and diaphyseal femoral fractures in a small number of patients." | 7.75 | Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy. ( Capeci, CM; Tejwani, NC, 2009) |
| "While alendronate therapy has been shown to decrease the risk of vertebral and femoral neck fractures in postmenopausal osteoporotic patients, recent reports have associated long-term alendronate therapy with unilateral low-energy subtrochanteric and diaphyseal femoral fractures in a small number of patients." | 3.75 | Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy. ( Capeci, CM; Tejwani, NC, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capeci, CM | 1 |
| Tejwani, NC | 1 |
| Levis, S | 1 |
| Quandt, SA | 1 |
| Thompson, D | 1 |
| Scott, J | 1 |
| Schneider, DL | 1 |
| Ross, PD | 1 |
| Black, D | 1 |
| Suryawanshi, S | 1 |
| Hochberg, M | 1 |
| Yates, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A 5-year, Double-blind, Randomized, Placebo-controlled Extension Study to Examine the Long-term Safety and Efficacy of Oral Alendronate in Postmenopausal Women Who Previously Received Alendronate in Conjunction With the Fracture Intervention Trial[NCT00398931] | Phase 3 | 1,099 participants (Actual) | Interventional | 1998-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for alendronate and Injuries, Multiple
| Article | Year |
|---|---|
Alendronate reduces the risk of multiple symptomatic fractures: results from the fracture intervention trial.
Topics: Aged; Alendronate; Double-Blind Method; Female; Follow-Up Studies; Fractures, Bone; Humans; Multiple | 2002 |
1 other study available for alendronate and Injuries, Multiple
| Article | Year |
|---|---|
Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy.
Topics: Aged; Alendronate; Bone Density Conservation Agents; Female; Femoral Fractures; Humans; Middle Aged; | 2009 |